1-4 of 4
Laura M. Spring
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception

Arielle J. Medford, Beverly Moy, Laura M. Spring, Sara A. Hurvitz, Nicholas C. Turner, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4540–4548.
https://doi.org/10.1158/1078-0432.CCR-23-0757
Published: 14 November 2023
View article titled, Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception
Open the PDF for Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception in another window
Journal Articles

Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor–positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities

Maxwell R. Lloyd, Laura M. Spring, Aditya Bardia, Seth A. Wander
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 821–830.
https://doi.org/10.1158/1078-0432.CCR-21-2947
Published: 01 March 2022
View article titled, Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor–positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities
Open the PDF for Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor–positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities in another window
Journal Articles

Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis

Laura M. Spring, Geoffrey Fell, Andrea Arfe, Chandni Sharma, Rachel Greenup, Kerry L. Reynolds, Barbara L. Smith, Brian Alexander, Beverly Moy, Steven J. Isakoff, Giovanni Parmigiani, Lorenzo Trippa, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2838–2848.
https://doi.org/10.1158/1078-0432.CCR-19-3492
Published: 15 June 2020
View article titled, Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Open the PDF for Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis in another window
Includes: Supplementary data
Journal Articles

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer

Joshua Z. Drago, Luigi Formisano, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A. Wander, Laura M. Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Megan Yuen, Giuliana Malvarosa, Dennis Sgroi, Steven J. Isakoff, Beverly Moy, Leif W. Ellisen, A. John Iafrate, Carlos L. Arteaga, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6443–6451.
https://doi.org/10.1158/1078-0432.CCR-19-0138
Published: 01 November 2019
View article titled, <em>FGFR1</em> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR<sup>+</sup>) Breast Cancer
Open the PDF for <em>FGFR1</em> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR<sup>+</sup>) Breast Cancer in another window
Includes: Supplementary data